Clinical Trial Update: No Surgery Trial / Two Dose-escalation Strategies [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating two dose-escalation strategies for rectal cancer with no surgery, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital | Conditions: Stage II Rectal Cancer | Phase 2, Phase 3 | Status: RECRUITING